Study Title: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Bhishamjit Chera, at cherabs@musc.edu.Study Coordinator, Kendall Preston, at prestoke@musc.edu.Trial opened at the following institutions: Medical University of South Carolina